Jan 29 (Reuters) - BIOFRONTERA AG:
* PTA-ADHOC: BIOFRONTERA AG: BIOFRONTERA RECEIVES FAVORABLE CHMP ASSESSMENT FOR AMELUZÂ® IN COMBINATION WITH DAYLIGHT PHOTODYNAMIC THERAPY
* BASED ON POSITIVE OPINION, CO ANTICIPATES FORMAL APPROVAL BY EUROPEAN COMMISSION IN COMING WEEKS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 